RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,376,063 | -26.6% | 1,406,502 | -17.4% | 0.00% | -50.0% |
| Q2 2023 | $31,828,242 | +5.8% | 1,702,045 | +3.8% | 0.00% | 0.0% |
| Q1 2023 | $30,076,494 | -60.9% | 1,639,046 | -57.8% | 0.00% | 0.0% |
| Q4 2022 | $76,852,630 | +150.7% | 3,881,446 | +204.7% | 0.00% | 0.0% |
| Q3 2022 | $30,650,000 | +242.2% | 1,273,891 | +159.5% | 0.00% | +100.0% |
| Q2 2022 | $8,958,000 | -69.8% | 490,865 | -63.6% | 0.00% | 0.0% |
| Q1 2022 | $29,633,000 | -35.1% | 1,347,581 | +8.3% | 0.00% | -50.0% |
| Q4 2021 | $45,684,000 | +326.7% | 1,243,787 | +260.7% | 0.00% | +100.0% |
| Q3 2021 | $10,707,000 | +24.5% | 344,837 | +27.5% | 0.00% | – |
| Q2 2021 | $8,598,000 | +99.5% | 270,456 | +39.3% | 0.00% | – |
| Q1 2021 | $4,310,000 | +12.9% | 194,166 | +0.4% | 0.00% | – |
| Q4 2020 | $3,819,000 | -36.4% | 193,372 | +3.8% | 0.00% | – |
| Q3 2020 | $6,000,000 | +16.2% | 186,328 | +4.7% | 0.00% | – |
| Q2 2020 | $5,164,000 | +906.6% | 177,949 | +637.4% | 0.00% | – |
| Q1 2020 | $513,000 | +89.3% | 24,133 | +146.3% | 0.00% | – |
| Q4 2019 | $271,000 | – | 9,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $49,189,395 | 17.79% |
| Euclidean Capital LLC | 432,900 | $7,943,715 | 6.97% |
| GREAT POINT PARTNERS LLC | 1,355,151 | $24,867,021 | 4.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 875,984 | $16,074,306 | 3.02% |
| Trustees of Columbia University in the City of New York | 80,580 | $1,478,643 | 2.64% |
| Perceptive Advisors | 2,291,608 | $42,051,007 | 1.24% |
| Cormorant Asset Management, LP | 650,000 | $11,928 | 0.79% |
| Alphabet Inc. | 540,270 | $9,913,955 | 0.55% |
| Redmile Group, LLC | 688,132 | $12,627,222 | 0.55% |
| Orbimed Advisors | 1,251,070 | $22,957,135 | 0.45% |